🔴 British Dragon

Mesterolone (Proviron)

✔️ Substance: Mesterolone
✔️ Price For: 50 tabs (25 mg/tab)
✔️ Brand: British Dragon

Out of stock

British Dragon Pharma Mesterolone 25

IDENTITYCompoundMesterolone
DerivativeDHT Derivative
Strength25 mg/tab
FormOral Tablet
ClassAndrogenic Steroid

PHARMACOLOGYRouteOral
TargetAndrogen Receptor
EstrogenNo Aromatization
StructureDHT Derived
SHBGHigh Affinity

SAFETYHPTA EffectSuppressive
Liver RiskPossible
Lipid RiskPossible
Androgenic RiskSignificant
MonitoringRecommended

STORAGE & PACKAGEBrandBritish Dragon Pharma
Package50 Tablets
Strength25 mg/tablet
StorageDry & Cool
ProtectionHeat & Moisture

DOSING Common Range25–100 mg/day
Frequency1–3x Daily
AdministrationOral Tablet
Typical Period4–8 Weeks
TimingSplit Daily Dose

USAGE PROFILEUseOral Administration
TimingConsistent Daily
Unitmg/day
Tablet25 mg
PeriodSeveral Weeks

RECOVERY SuppressionPossible
RecoveryVariable
PCTNo Standard Protocol
TestingHormonal Panel
Follow-upClinician Guided

STACKING/COMPATIBILITYTestosteroneCommon Combination
Other DHTsAdded Androgenic Load
Oral AASAdded Lipid Risk
AINot Automatically Required
MonitoringLipids & Hormones

MECHANISM OF ACTIONTargetAndrogen Receptor
OriginDHT Derivative
SHBGStrong Binding
AromataseNot Aromatized
SignalAndrogenic Activity

PHARMACOKINETICSRouteOral
AbsorptionGastrointestinal
MetabolismHepatic
Half-LifeAbout 12–13 Hours
ExposureDaily Administration

CONTRAINDICATIONSPregnancyContraindicated
ProstateAssess Clinically
LiverAssess Function
CardiacRisk Assessment
LipidsMonitor Closely

CHEMICAL PROFILEFormulaC20H32O2
Weight304.47 g/mol
CAS1424-00-6
ClassAndrostane Derivative
Structure1α-Methyl-DHT

COMPARISONS/ALTERNATIVESMesteroloneOral DHT Derivative
DrostanoloneInjectable DHT Derivative
MethenoloneDHT Related
OxandroloneOral DHT Derivative
TestosteroneAromatizable Androgen

WHO IT'S FORClinical UseSpecific Indications
AthletesNon-Medical Use
WomenVirilization Risk
MonitoringHealthcare Guided
PurposeMedical Assessment

BODYBUILDING USAGE

Often discussed during cutting phases
DHT-derived androgenic profile
No direct aromatization
May affect androgen signaling
Often discussed with testosterone
Hormonal suppression remains possible
Lipid monitoring remains important

WHAT IS BRITISH DRAGON?

British Dragon Pharma is the brand identified for this Mesterolone product. Brand-specific manufacturing, formulation, quality-control procedures and product authenticity should not be inferred solely from a brand name and should be verified through reliable product documentation.

WHY CHOOSE BRITISH DRAGON?

Clearly stated active compound
Defined tablet strength
Identified oral presentation
Specified package quantity
Product documentation matters
Independent verification recommended

OVERVIEW

Mesterolone is a synthetic androgen structurally related to dihydrotestosterone (DHT). It is an orally active androgen that has been used medically in some countries for male androgen deficiency and selected fertility-related indications. DrugBank classifies mesterolone as an anabolic steroid and identifies the androgen receptor among its pharmacological targets. DrugBank information.

BENEFITS

DHT-derived androgenic activity
Oral administration
No direct aromatization
Strong androgen-receptor interaction
SHBG binding activity
Defined tablet concentration
Established pharmacological identity

POTENTIAL SIDE EFFECTS

Endogenous testosterone suppression
Adverse lipid changes
Blood pressure changes
Acne and oily skin
Accelerated hair loss
Prostate-related effects
Virilization in women
Mood changes
Possible liver effects

PERFORMANCE PROFILE

Androgen Activity

82%

Muscle Support

62%

SHBG Binding

80%

Water Retention

12%

Aromatization

MESTEROLONE FOR SALE

British Dragon Pharma Mesterolone 25 mg is presented as an oral tablet containing mesterolone. Product identity, concentration, manufacturing quality, authenticity and regulatory status should be independently verified before any pharmaceutical product is considered.

CONCLUSION

British Dragon Pharma Mesterolone 25 mg is identified as an oral mesterolone preparation containing a DHT-derived androgen. Its pharmacological characteristics include androgen-receptor activity, substantial SHBG interaction and the absence of direct aromatization to estrogen.

For bodybuilding-oriented educational content, mesterolone is commonly discussed in relation to cutting phases, androgenic support and combinations with other anabolic-androgenic steroids. However, these performance applications are not established therapeutic indications. European regulatory authorities have specifically strengthened warnings concerning mesterolone abuse as an image- and performance-enhancing substance. EMA safety documentation.

Non-medical use can involve endocrine suppression, adverse cardiovascular and lipid effects, androgenic complications, hepatic concerns and psychiatric effects. The appropriate interpretation of any bodybuilding protocol therefore requires consideration of the compound's pharmacology and its potential risks rather than treating an athletic dosing schedule as an established medical regimen.

Disclaimer

This content is provided exclusively for educational and informational purposes. It does not constitute medical advice, treatment recommendations or endorsement of non-medical anabolic steroid use. Mesterolone is not an approved bodybuilding or performance-enhancing treatment, and athletic dosing protocols are not established clinical standards. Anabolic-androgenic steroid misuse can involve serious cardiovascular, hepatic, endocrine and psychiatric risks. Readers should consult qualified healthcare professionals regarding medical questions, laboratory monitoring and applicable laws in their jurisdiction.